Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB206 in Molluscum Contagiosum
NCT03436615Phase 2Completed
- Sponsor
- Novan
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Polymer-based Nanoparticles, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of berdazimer in molluscum contagiosum (MC), sponsored by Novan. Started Jan 2018; status: completed.
02
Drugs
berdazimer
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on NCT03436615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436615.